Breast Cancer Webinar

October 20, 2020

Author: Acteropharma

Simultaneously with the unveiling of Onkotaxel (Docetaxel of Actero Company), a subspecialized webinar was held on July 23rd with the presence of Dr. Safa Najafi (Medical Oncologist), Dr. Samiei (Radiotherapy Oncologist), Dr. Azimi Nejadan (Surgeon) and Ms. Dr. Ehsani (Pathologist) on August 2. The webinar discussed the latest updates in breast cancer diagnosis and treatment, with 344 live broadcast participants and 203 replay viewers.

Last News

Actero Support in Congress 1400

July 24, 2022

Author:

Acteropharma

Actero company’s social respomsibility of patient support in Hematology-Oncology Congress and Radiation Therapy Congress

Best of ASCO 2021

November 16, 2021

Author:

Acteropharma

The aforesaid seminar has been held for the first time in Iran with the hospitality of Isfahan city, with the cooperation of Radiation-Oncologists from all over of the country and Actero Pharma.

“Uro-Oncology Tumor board: Challenges of Prostate Cancer Treatment” (Semi-Virtual)

November 16, 2021

Author:

Acteropharma

Uro-Oncology research Center of Tehran University of Medical science, in cooperation with Actero Pharma has held a semi-virtual tumor board.